Science and Technology

Green hydrogen was once portrayed as a transformative answer capable of decarbonizing almost every corner of the global economy, inspiring government master plans, a surge of investor funding for electrolyzer ventures, and bold forecasts of swift cost reductions; now, the storyline has become more restrained, with green hydrogen steadily carving out a role in select, high‑value niches where it addresses challenges that electricity alone cannot resolve, and this evolution from broad hype to focused deployment reflects hard‑earned insights about costs, infrastructure demands, and practical limitations.Exploring Green Hydrogen and Its Initial Surge of EnthusiasmGreen hydrogen is produced by splitting water through…

Freshwater scarcity has evolved from a localized issue into a global strategic challenge. Expanding populations, accelerating urban growth, rising industrial needs, climate instability, and deteriorating infrastructure are collectively putting intense pressure on traditional water resources. Consequently, water desalination and purification technologies are progressing swiftly, propelled by demands for greater resilience, cost-efficiency, and environmental responsibility. Innovation is shifting from a discretionary effort to an essential element of national water security plans and private-sector investment strategies.Climate Change and Intensifying Water StressClimate change stands among the most influential drivers behind advances in desalination and purification, as increasing temperatures, altered rainfall patterns, and extended…

The rapid expansion of digital compute—driven by cloud services, artificial intelligence, high-performance computing, and edge processing—has become one of the fastest-growing sources of electricity demand. Large data centers now rival heavy industry in power intensity, while smaller edge facilities are proliferating across cities. Training and operating advanced models can require continuous, high-density power with tight reliability requirements. As a result, electric grids that were designed for predictable growth and centralized generation are adapting to a more volatile, location-specific, and time-sensitive load profile.How demand attributes are evolvingCompute-driven demand differs from traditional loads in several ways:Density: Contemporary data centers may draw more…

US researchers have created a nasal spray vaccine that may offer broad protection against numerous respiratory infections such as coughs, colds, flu, and specific bacterial diseases, while also lowering allergic responses. Initial animal testing indicates it activates the immune system through an innovative mechanism, although human trials remain necessary.Scientists at Stanford University are testing what they call a "universal vaccine" that represents a significant shift from conventional vaccination approaches. Unlike traditional vaccines, which target a single pathogen, this vaccine triggers a broad immune alert in the lungs, preparing white blood cells—known as macrophages—to respond rapidly to a variety of infections.…

Modern AI systems are no longer constrained primarily by raw compute. Training and inference for deep learning models involve moving massive volumes of data between processors and memory. As model sizes scale from millions to hundreds of billions of parameters, the memory wall—the gap between processor speed and memory throughput—becomes the dominant performance bottleneck.Graphics processing units and AI accelerators are capable of performing trillions of operations per second, yet their performance can falter when data fails to arrive quickly enough. At this point, memory breakthroughs like High Bandwidth Memory (HBM) become essential.Why HBM Stands Apart at Its CoreHBM is a…

Gene therapy aims to treat disease by adding, editing, or regulating genetic material within a patient’s cells. The effectiveness of these therapies depends less on the genetic instructions themselves and more on how precisely, safely, and efficiently those instructions reach the right cells. Early gene therapies struggled with immune reactions, limited targeting, and short-lived effects. New delivery methods are changing that landscape by improving accuracy, durability, and safety while expanding the range of treatable diseases.Cutting-edge viral vector platformsViral vectors remain a central delivery tool because viruses naturally enter cells. Recent advances focus on making them more selective and less likely…